Global Anesthesia Drug Market research

Anesthesia Drug Comprehensive Study by Type (General Anesthesia Drugs (Propofol, Sevoflurane, Desflurane, Dexmedetomidine, Remifentanil, Midazolam, Other General Anesthesia Drugs), Local Anesthesia Drugs (Bupivacaine,Ropivacaine,Lidocaine,Chloroprocaine,Articaine,Benzocaine)), Application (General Surgeries, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries, Other Applications), Route of Administration (Inhalation, Injection, Other) Players and Region - Global Market Outlook to 2028

Anesthesia Drug Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Anesthesia Drug Market Scope?
An anesthesia drug used to result in a temporary loss of sensation. The anesthesia drug market is expected to grow in the future due to the rising number of surgeries and the increasing geriatric population. The increasing healthcare expenditure and advancements in drug delivery technologies will boost the anesthesia drug market in the future. Market players are totally focusing on new drug development with less price will propelling the growth of the market.

Influencing Trend:
Advancements in Drug Delivery Technologies

Market Growth Drivers:
Rising Number of Surgeries due to Increasing Risk of Various Accidents, Diseases, and Sports Injuries, Cosmetic Surgeries, and Plastic Surgeries, Globally and Introduction of New and Effective Drugs in Less Price

Challenges:
Side Effects of General Anesthetics such as Nausea, Vomiting, etc

Restraints:
Stringent Government Regulation on Drugs

Opportunities:
Increasing Healthcare Expenditure in developing countries such as India, China, and Brazil and Rapid Research and Development Activity in Anesthesia Drug Sector

The Anesthesia Drug market study is being classified by Type (General Anesthesia Drugs (Propofol, Sevoflurane, Desflurane, Dexmedetomidine, Remifentanil, Midazolam, Other General Anesthesia Drugs) and Local Anesthesia Drugs (Bupivacaine,Ropivacaine,Lidocaine,Chloroprocaine,Articaine,Benzocaine)), by Application and major geographies with country level break-up.

The global anesthesia drug market is fragmented with numerous market players. Due to the rising drug approvals, mid-size to smaller companies are increasing their market presence by introducing new ingredients with fewer prices. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Anesthesia Drug market throughout the predicted period.

Abbott Laboratories (United States), Baxter (United States), Novartis International AG (Switzerland), Mylan N.V. (United States), Hikma Pharmaceuticals (United Kingdom), AstraZeneca plc (United Kingdom), Fresenius Kabi (Germany), AbbVie (United States) and B. Braun Melsungen AG (Germany) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are The Piramal Group (India) and Hengrui Therapeutics, Inc.(United States).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Anesthesia Drug market by Type, Application and Region.

On the basis of geography, the market of Anesthesia Drug has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their Development Strategies
In December 2021, Baxter International Inc. acquired Hillrom for paid USD 156.00 in cash for each outstanding share of Hillrom common stock for a purchase price of USD 10.5 billion. This helped company to expand its presence in anesthesia drug market
In Sept 2019, Hikma Pharmaceuticals PLC launched Phenylephrine Hydrochloride Injection, USP, 5mL and 10mL pharmacy bulk package vials, in the United States through its US affiliate, Hikma Pharmaceuticals USA Inc.


Key Target Audience
Anesthesia Drug Manufacturers, Anesthesia Drug Suppliers, Medical Research Laboratories, Research and Development (R&D) Companies, Market Research and Consulting Service Providers and Potential Investors

Anesthesia Drug Market Study: Important Years
AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Major Highlights of Market Study

Demand Determinants: Identifying top-notch application and business segments that seek high growth potentials in Anesthesia Drug Market.

Key Strategic Developments: To target untapped regions more aggressively by focusing on product/service developments, innovation and R & D, new launches, Merger & acquisitions, JVs & partnerships.

Forces & Market Dynamics: Growth drivers, restraints & opportunities available in Anesthesia Drug industry is examined with reference relevant market sectors and sub-sectors.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also includes significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets, To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • General Anesthesia Drugs (Propofol, Sevoflurane, Desflurane, Dexmedetomidine, Remifentanil, Midazolam, Other General Anesthesia Drugs)
  • Local Anesthesia Drugs (Bupivacaine,Ropivacaine,Lidocaine,Chloroprocaine,Articaine,Benzocaine)
By Application
  • General Surgeries
  • Plastic Surgery
  • Cosmetic Surgeries
  • Dental Surgeries
  • Other Applications
By Route of Administration
  • Inhalation
  • Injection
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Number of Surgeries due to Increasing Risk of Various Accidents, Diseases, and Sports Injuries, Cosmetic Surgeries, and Plastic Surgeries, Globally
      • 3.2.2. Introduction of New and Effective Drugs in Less Price
    • 3.3. Market Challenges
      • 3.3.1. Side Effects of General Anesthetics such as Nausea, Vomiting, etc
    • 3.4. Market Trends
      • 3.4.1. Advancements in Drug Delivery Technologies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Anesthesia Drug, by Type, Application, Route of Administration and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Anesthesia Drug (Value)
      • 5.2.1. Global Anesthesia Drug by: Type (Value)
        • 5.2.1.1. General Anesthesia Drugs (Propofol, Sevoflurane, Desflurane, Dexmedetomidine, Remifentanil, Midazolam, Other General Anesthesia Drugs)
        • 5.2.1.2. Local Anesthesia Drugs (Bupivacaine,Ropivacaine,Lidocaine,Chloroprocaine,Articaine,Benzocaine)
      • 5.2.2. Global Anesthesia Drug by: Application (Value)
        • 5.2.2.1. General Surgeries
        • 5.2.2.2. Plastic Surgery
        • 5.2.2.3. Cosmetic Surgeries
        • 5.2.2.4. Dental Surgeries
        • 5.2.2.5. Other Applications
      • 5.2.3. Global Anesthesia Drug by: Route of Administration (Value)
        • 5.2.3.1. Inhalation
        • 5.2.3.2. Injection
        • 5.2.3.3. Other
      • 5.2.4. Global Anesthesia Drug Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Anesthesia Drug (Price)
      • 5.3.1. Global Anesthesia Drug by: Type (Price)
  • 6. Anesthesia Drug: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Baxter (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Novartis International AG (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Mylan N.V. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Hikma Pharmaceuticals (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. AstraZeneca plc (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Fresenius Kabi (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. AbbVie (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. B. Braun Melsungen AG (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Anesthesia Drug Sale, by Type, Application, Route of Administration and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Anesthesia Drug (Value)
      • 7.2.1. Global Anesthesia Drug by: Type (Value)
        • 7.2.1.1. General Anesthesia Drugs (Propofol, Sevoflurane, Desflurane, Dexmedetomidine, Remifentanil, Midazolam, Other General Anesthesia Drugs)
        • 7.2.1.2. Local Anesthesia Drugs (Bupivacaine,Ropivacaine,Lidocaine,Chloroprocaine,Articaine,Benzocaine)
      • 7.2.2. Global Anesthesia Drug by: Application (Value)
        • 7.2.2.1. General Surgeries
        • 7.2.2.2. Plastic Surgery
        • 7.2.2.3. Cosmetic Surgeries
        • 7.2.2.4. Dental Surgeries
        • 7.2.2.5. Other Applications
      • 7.2.3. Global Anesthesia Drug by: Route of Administration (Value)
        • 7.2.3.1. Inhalation
        • 7.2.3.2. Injection
        • 7.2.3.3. Other
      • 7.2.4. Global Anesthesia Drug Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Anesthesia Drug (Price)
      • 7.3.1. Global Anesthesia Drug by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Anesthesia Drug: by Type(USD Million)
  • Table 2. Anesthesia Drug General Anesthesia Drugs (Propofol, Sevoflurane, Desflurane, Dexmedetomidine, Remifentanil, Midazolam, Other General Anesthesia Drugs) , by Region USD Million (2017-2022)
  • Table 3. Anesthesia Drug Local Anesthesia Drugs (Bupivacaine,Ropivacaine,Lidocaine,Chloroprocaine,Articaine,Benzocaine) , by Region USD Million (2017-2022)
  • Table 4. Anesthesia Drug: by Application(USD Million)
  • Table 5. Anesthesia Drug General Surgeries , by Region USD Million (2017-2022)
  • Table 6. Anesthesia Drug Plastic Surgery , by Region USD Million (2017-2022)
  • Table 7. Anesthesia Drug Cosmetic Surgeries , by Region USD Million (2017-2022)
  • Table 8. Anesthesia Drug Dental Surgeries , by Region USD Million (2017-2022)
  • Table 9. Anesthesia Drug Other Applications , by Region USD Million (2017-2022)
  • Table 10. Anesthesia Drug: by Route of Administration(USD Million)
  • Table 11. Anesthesia Drug Inhalation , by Region USD Million (2017-2022)
  • Table 12. Anesthesia Drug Injection , by Region USD Million (2017-2022)
  • Table 13. Anesthesia Drug Other , by Region USD Million (2017-2022)
  • Table 14. South America Anesthesia Drug, by Country USD Million (2017-2022)
  • Table 15. South America Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 16. South America Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 17. South America Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 18. Brazil Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 19. Brazil Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 20. Brazil Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 21. Argentina Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 22. Argentina Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 23. Argentina Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 24. Rest of South America Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 25. Rest of South America Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 26. Rest of South America Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 27. Asia Pacific Anesthesia Drug, by Country USD Million (2017-2022)
  • Table 28. Asia Pacific Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 29. Asia Pacific Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 30. Asia Pacific Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 31. China Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 32. China Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 33. China Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 34. Japan Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 35. Japan Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 36. Japan Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 37. India Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 38. India Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 39. India Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 40. South Korea Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 41. South Korea Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 42. South Korea Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 43. Taiwan Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 44. Taiwan Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 45. Taiwan Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 46. Australia Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 47. Australia Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 48. Australia Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 49. Rest of Asia-Pacific Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 50. Rest of Asia-Pacific Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 51. Rest of Asia-Pacific Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 52. Europe Anesthesia Drug, by Country USD Million (2017-2022)
  • Table 53. Europe Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 54. Europe Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 55. Europe Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 56. Germany Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 57. Germany Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 58. Germany Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 59. France Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 60. France Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 61. France Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 62. Italy Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 63. Italy Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 64. Italy Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 65. United Kingdom Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 66. United Kingdom Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 67. United Kingdom Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 68. Netherlands Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 69. Netherlands Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 70. Netherlands Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 71. Rest of Europe Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 72. Rest of Europe Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 73. Rest of Europe Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 74. MEA Anesthesia Drug, by Country USD Million (2017-2022)
  • Table 75. MEA Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 76. MEA Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 77. MEA Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 78. Middle East Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 79. Middle East Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 80. Middle East Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 81. Africa Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 82. Africa Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 83. Africa Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 84. North America Anesthesia Drug, by Country USD Million (2017-2022)
  • Table 85. North America Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 86. North America Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 87. North America Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 88. United States Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 89. United States Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 90. United States Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 91. Canada Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 92. Canada Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 93. Canada Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 94. Mexico Anesthesia Drug, by Type USD Million (2017-2022)
  • Table 95. Mexico Anesthesia Drug, by Application USD Million (2017-2022)
  • Table 96. Mexico Anesthesia Drug, by Route of Administration USD Million (2017-2022)
  • Table 97. Anesthesia Drug: by Type(USD/Units)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Anesthesia Drug: by Type(USD Million)
  • Table 108. Anesthesia Drug General Anesthesia Drugs (Propofol, Sevoflurane, Desflurane, Dexmedetomidine, Remifentanil, Midazolam, Other General Anesthesia Drugs) , by Region USD Million (2023-2028)
  • Table 109. Anesthesia Drug Local Anesthesia Drugs (Bupivacaine,Ropivacaine,Lidocaine,Chloroprocaine,Articaine,Benzocaine) , by Region USD Million (2023-2028)
  • Table 110. Anesthesia Drug: by Application(USD Million)
  • Table 111. Anesthesia Drug General Surgeries , by Region USD Million (2023-2028)
  • Table 112. Anesthesia Drug Plastic Surgery , by Region USD Million (2023-2028)
  • Table 113. Anesthesia Drug Cosmetic Surgeries , by Region USD Million (2023-2028)
  • Table 114. Anesthesia Drug Dental Surgeries , by Region USD Million (2023-2028)
  • Table 115. Anesthesia Drug Other Applications , by Region USD Million (2023-2028)
  • Table 116. Anesthesia Drug: by Route of Administration(USD Million)
  • Table 117. Anesthesia Drug Inhalation , by Region USD Million (2023-2028)
  • Table 118. Anesthesia Drug Injection , by Region USD Million (2023-2028)
  • Table 119. Anesthesia Drug Other , by Region USD Million (2023-2028)
  • Table 120. South America Anesthesia Drug, by Country USD Million (2023-2028)
  • Table 121. South America Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 122. South America Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 123. South America Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 124. Brazil Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 125. Brazil Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 126. Brazil Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 127. Argentina Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 128. Argentina Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 129. Argentina Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 130. Rest of South America Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 131. Rest of South America Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 132. Rest of South America Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 133. Asia Pacific Anesthesia Drug, by Country USD Million (2023-2028)
  • Table 134. Asia Pacific Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 135. Asia Pacific Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 136. Asia Pacific Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 137. China Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 138. China Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 139. China Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 140. Japan Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 141. Japan Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 142. Japan Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 143. India Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 144. India Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 145. India Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 146. South Korea Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 147. South Korea Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 148. South Korea Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 149. Taiwan Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 150. Taiwan Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 151. Taiwan Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 152. Australia Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 153. Australia Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 154. Australia Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 155. Rest of Asia-Pacific Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 156. Rest of Asia-Pacific Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 157. Rest of Asia-Pacific Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 158. Europe Anesthesia Drug, by Country USD Million (2023-2028)
  • Table 159. Europe Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 160. Europe Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 161. Europe Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 162. Germany Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 163. Germany Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 164. Germany Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 165. France Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 166. France Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 167. France Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 168. Italy Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 169. Italy Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 170. Italy Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 171. United Kingdom Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 172. United Kingdom Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 173. United Kingdom Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 174. Netherlands Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 175. Netherlands Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 176. Netherlands Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 177. Rest of Europe Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 178. Rest of Europe Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 179. Rest of Europe Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 180. MEA Anesthesia Drug, by Country USD Million (2023-2028)
  • Table 181. MEA Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 182. MEA Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 183. MEA Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 184. Middle East Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 185. Middle East Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 186. Middle East Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 187. Africa Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 188. Africa Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 189. Africa Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 190. North America Anesthesia Drug, by Country USD Million (2023-2028)
  • Table 191. North America Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 192. North America Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 193. North America Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 194. United States Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 195. United States Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 196. United States Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 197. Canada Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 198. Canada Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 199. Canada Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 200. Mexico Anesthesia Drug, by Type USD Million (2023-2028)
  • Table 201. Mexico Anesthesia Drug, by Application USD Million (2023-2028)
  • Table 202. Mexico Anesthesia Drug, by Route of Administration USD Million (2023-2028)
  • Table 203. Anesthesia Drug: by Type(USD/Units)
  • Table 204. Research Programs/Design for This Report
  • Table 205. Key Data Information from Secondary Sources
  • Table 206. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Anesthesia Drug: by Type USD Million (2017-2022)
  • Figure 5. Global Anesthesia Drug: by Application USD Million (2017-2022)
  • Figure 6. Global Anesthesia Drug: by Route of Administration USD Million (2017-2022)
  • Figure 7. South America Anesthesia Drug Share (%), by Country
  • Figure 8. Asia Pacific Anesthesia Drug Share (%), by Country
  • Figure 9. Europe Anesthesia Drug Share (%), by Country
  • Figure 10. MEA Anesthesia Drug Share (%), by Country
  • Figure 11. North America Anesthesia Drug Share (%), by Country
  • Figure 12. Global Anesthesia Drug: by Type USD/Units (2017-2022)
  • Figure 13. Global Anesthesia Drug share by Players 2022 (%)
  • Figure 14. Global Anesthesia Drug share by Players (Top 3) 2022(%)
  • Figure 15. Global Anesthesia Drug share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 18. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 19. Baxter (United States) Revenue, Net Income and Gross profit
  • Figure 20. Baxter (United States) Revenue: by Geography 2022
  • Figure 21. Novartis International AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 22. Novartis International AG (Switzerland) Revenue: by Geography 2022
  • Figure 23. Mylan N.V. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Mylan N.V. (United States) Revenue: by Geography 2022
  • Figure 25. Hikma Pharmaceuticals (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. Hikma Pharmaceuticals (United Kingdom) Revenue: by Geography 2022
  • Figure 27. AstraZeneca plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. AstraZeneca plc (United Kingdom) Revenue: by Geography 2022
  • Figure 29. Fresenius Kabi (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Fresenius Kabi (Germany) Revenue: by Geography 2022
  • Figure 31. AbbVie (United States) Revenue, Net Income and Gross profit
  • Figure 32. AbbVie (United States) Revenue: by Geography 2022
  • Figure 33. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 34. B. Braun Melsungen AG (Germany) Revenue: by Geography 2022
  • Figure 35. Global Anesthesia Drug: by Type USD Million (2023-2028)
  • Figure 36. Global Anesthesia Drug: by Application USD Million (2023-2028)
  • Figure 37. Global Anesthesia Drug: by Route of Administration USD Million (2023-2028)
  • Figure 38. South America Anesthesia Drug Share (%), by Country
  • Figure 39. Asia Pacific Anesthesia Drug Share (%), by Country
  • Figure 40. Europe Anesthesia Drug Share (%), by Country
  • Figure 41. MEA Anesthesia Drug Share (%), by Country
  • Figure 42. North America Anesthesia Drug Share (%), by Country
  • Figure 43. Global Anesthesia Drug: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Baxter (United States)
  • Novartis International AG (Switzerland)
  • Mylan N.V. (United States)
  • Hikma Pharmaceuticals (United Kingdom)
  • AstraZeneca plc (United Kingdom)
  • Fresenius Kabi (Germany)
  • AbbVie (United States)
  • B. Braun Melsungen AG (Germany)
Additional players considered in the study are as follows:
The Piramal Group (India) , Hengrui Therapeutics, Inc.(United States)
Select User Access Type

Key Highlights of Report


Jun 2023 209 Pages 51 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Anesthesia Drug Market research Quantitative research analysis
Global Anesthesia Drug Market research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The prominent players of Global Anesthesia Drug market are Abbott Laboratories (United States), Baxter (United States), Novartis International AG (Switzerland), Mylan N.V. (United States), Hikma Pharmaceuticals (United Kingdom), AstraZeneca plc (United Kingdom), Fresenius Kabi (Germany), AbbVie (United States) and B. Braun Melsungen AG (Germany).
In this highly competitive & fast evolving Anesthesia Drug industry, the top strategic priorities would remain consistent like innovation, R&D, and M&A.
General Surgeries, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries and Other Applications are the potential customers of Anesthesia Drug industry.

Know More About Global Anesthesia Drug Market research Report?

Have a Query? Click Here

Other Related Reports

Celiac Disease Drug Comprehensive Study by Application (Hospitals, Clinics, Other), Distribution Channel (Over the Counter (OTC), Prescribed Medicine), Treatment Type (First-Line Treatment, Second-Li...
$ 3500
H1N1 (swine flu) Vaccination Comprehensive Study by Treatment type (Influenza, Meningococcal, Cervical cancer, Pneumococcal, Hepatitis, Measles, Mumps, Rubella), End user (Hospital, Clinics) Players ...
$ 3500
Follicle Stimulating Hormone Comprehensive Study by Type (Recombinant FSH, Urinary FSH), Application (Infertility Treatment, Assisted Reproductive Technology), End User (Man, Woman, Child) Players an...
$ 3800
Protein Expression Comprehensive Study by Application (Therapeutic, Research, Industrial), Systems Type (Prokaryotic Expression Systems {Escherichia coli (E. coli) Systems and Other Systems}, Mammali...
$ 3750
Regenerative Medicine Comprehensive Study by Type (Cell-Based, Acellular), Application (Cardiovascular, Oncology, Dermatology, Wound Healing, Neurology, Others), Technology (Stem Cell Therapy, Platel...
$ 3450
Glucagon Comprehensive Study by Type (Glucagon Like Peptide 1, Glucagon Like Peptide 2), Application (Hypoglycemia, Radiologic Examination, Cardiogenic Shock, Emergency Kits, Others), End Users (Hosp...
$ 3800